Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Oscar Health Q2 2024 GAAP EPS $0.20 Beats $0.16 Estimate, Sales $2.219B Beat $2.155B Estimate

Author: Benzinga Newsdesk | August 07, 2024 06:01am
Oscar Health (NYSE:OSCR) reported quarterly earnings of $0.20 per share which beat the analyst consensus estimate of $0.16 by 25 percent. This is a 385.71 percent increase over losses of $(0.07) per share from the same period last year. The company reported quarterly sales of $2.219 billion which beat the analyst consensus estimate of $2.155 billion by 2.99 percent. This is a 45.89 percent increase over sales of $1.521 billion the same period last year.

Posted In: OSCR


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist